| Loss of PTEN promotes resistance to T cell–mediated immunotherapy W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... Cancer discovery 6 (2), 202-216, 2016 | 1368 | 2016 |
| Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy T Cascone, JA McKenzie, RM Mbofung, S Punt, Z Wang, C Xu, ... Cell metabolism 27 (5), 977-987. e4, 2018 | 471 | 2018 |
| RNA editing derived epitopes function as cancer antigens to elicit immune responses M Zhang, J Fritsche, J Roszik, LJ Williams, X Peng, Y Chiu, CC Tsou, ... Nature communications 9 (1), 3919, 2018 | 124 | 2018 |
| HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes RM Mbofung, JA McKenzie, S Malu, M Zhang, W Peng, C Liu, I Kuiatse, ... Nature communications 8 (1), 451, 2017 | 121 | 2017 |
| The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression L Huang, S Malu, JA McKenzie, MC Andrews, AH Talukder, T Tieu, ... Clinical Cancer Research 24 (14), 3366-3376, 2018 | 87 | 2018 |
| The effect of topoisomerase I inhibitors on the efficacy of T-cell-based cancer immunotherapy JA McKenzie, RM Mbofung, S Malu, M Zhang, E Ashkin, S Devi, ... JNCI: Journal of the National Cancer Institute 110 (7), 777-786, 2018 | 74 | 2018 |
| The glutaminase inhibitor CB-839 (telaglenastat) enhances the antimelanoma activity of T-cell–mediated immunotherapies S Varghese, S Pramanik, LJ Williams, HR Hodges, CW Hudgens, ... Molecular cancer therapeutics 20 (3), 500-511, 2021 | 73 | 2021 |
| Superior efficacy of neoadjuvant compared to adjuvant immune checkpoint blockade in non-small cell lung cancer T Cascone, H Hamdi, F Zhang, A Poteete, L Li, CW Hudgens, LJ Williams, ... Cancer Research 78 (13_Supplement), 1719-1719, 2018 | 46 | 2018 |
| Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma W Peng, LJ Williams, C Xu, B Melendez, JA McKenzie, Y Chen, ... Clinical Cancer Research 25 (21), 6406-6416, 2019 | 41 | 2019 |
| Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators J Hou, Y Wang, L Shi, Y Chen, C Xu, A Saeedi, K Pan, R Bohat, NA Egan, ... Journal for immunotherapy of cancer 9 (2), 2021 | 25 | 2021 |
| LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade A Hickman, J Koetsier, T Kurtanich, MC Nielsen, G Winn, Y Wang, ... The Journal of clinical investigation 132 (13), 2022 | 19 | 2022 |
| Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity S Punt, S Malu, JA McKenzie, SZ Manrique, EM Doorduijn, RM Mbofung, ... Cancer Immunology, Immunotherapy 70, 1101-1113, 2021 | 19 | 2021 |
| Inhibiting type I arginine methyltransferase activity promotes T cell–mediated antitumor immune responses A Fedoriw, L Shi, S O'Brien, KN Smitheman, Y Wang, J Hou, C Sherk, ... Cancer immunology research 10 (4), 420-436, 2022 | 17 | 2022 |
| Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6 (2): 202–16 W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff External Resources Crossref (DOI), 0 | 17 | |
| Tidier descriptions of speech and language therapy interventions for people with aphasia; consensus from the RELEASE collaboration ML Rose, M Ali, A Elders, J Godwin, A Karachalia Sandri, LJ Williams, ... Aphasiology 32 (sup1), 183-186, 2018 | 8 | 2018 |
| Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6: 202–16 W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... PUBMED, 0 | 8 | |
| Complex speech-language therapy interventions for stroke-related aphasia: the RELEASE study incorporating a systematic review and individual participant data network meta-analysis MC Brady, M Ali, KV Berg, LJ Williams, LR Williams, M Abo, F Becker, ... Health and Social Care Delivery Research 10 (28), 2022 | 5 | 2022 |
| Weiyi Peng C Liu, L Williams, C Xu, RM Mbofung Abstracts: AACR Virtual Special Conference: Endometrial Cancer: New Biology …, 2020 | 5 | 2020 |
| Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens MR Schlabach, S Lin, ZR Collester, C Wrocklage, S Shenker, C Calnan, ... Journal of Clinical Investigation 133 (24), e163096, 2023 | 1 | 2023 |
| Early drug prescription patterns as predictors of final workers compensation claim costs and closure: an updated analysis on an expanded cohort XG Tao, RA Lavin, L Yuspeh, NF Tsourmas, N Kalia, N Leung, L Williams, ... Journal of occupational and environmental medicine 64 (12), 1046-1052, 2022 | 1 | 2022 |
